cbdMD: Akretive holds 2.23M shares after acquisition
Akretive Holdings LLC is identified as a 10% owner, with the reported common-stock position held directly.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
cbdMD, Inc. (YCBD) reports that Akretive Holdings LLC, a 10% owner, held 2,229,805 shares of common stock directly following an acquisition effective October 30, 2026. The acquisition was made under an Asset Purchase Agreement dated September 1, 2026, among cbdMD, To Be Brands, LLC, Twinlab Consolidated Holdings, Inc., Philip J. Von Kahle as the duly appointed assignee, and Akretive Holdings LLC.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Holding | Common Stock F1 | -- | -- | -- |
Footnotes (1)
- F1. The Reporting Person acquired the shares pursuant to an Asset Purchase Agreement dated September 1, 2026, by and among the Issuer, To Be Brands, LLC, Twinlab Consolidated Holdings, Inc., Twinlab Consolidated Holdings, Inc., Philip J. Von Kahle, in his capacity as the duly appointed assignee, and the Reporting Person effective October 30, 2026.
Key Figures
Key Terms
Asset Purchase Agreement technical
duly appointed assignee regulatory
Reporting Person regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.